Evaluation of the Self-Testing Blood Glucose Monitoring System GlucoDr.S According to ISO 15197:2013 Guidelines
Laboratory Medicine Online
; : 77-86, 2018.
Article
en Ko
| WPRIM
| ID: wpr-715913
Biblioteca responsable:
WPRO
ABSTRACT
BACKGROUND:
The performance of the self-monitoring of blood glucose in patients with diabetes should be properly evaluated to ensure strict glycemic control. This study evaluated the self-testing Blood Glucose Monitoring System GlucoDr.S™ (All Medicus Co., Ltd., Korea).METHODS:
This study recruited 120 patients. Use of the glucometer was evaluated according to ISO 151972013 guidelines. The YSI 2300 STAT PLUS Glucose Analyzer (YSI Life Sciences, USA) was used as the reference device.RESULTS:
The standard deviation and coefficients of variation ranges for measurement repeatability and intermediate measurement precision conducted with 10 meters and 3 reagent lots on the same day were 2.7–3.2 mg/dL (0.99. The influence effect of hematocrit and the 24 interference agents was not significant, except for xylose. A system accuracy test was conducted with 100 subjects taking duplicate measurements from each of the 3 reagent lots. When glucose levels were 95% of the samples were within ±15 mg/dL and within ±15% of the average measured values of the reference measurement, respectively. In Consensus Error grid analysis, all results were distributed in zone A and B. The results of the user performance evaluation using 115 lay persons were also included in the acceptance range.CONCLUSION:
The GlucoDr.S™ showed acceptable performance according to the ISO 151972013 guidelines and could be a clinically useful self-testing glucometer.Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Xilosa
/
Glucemia
/
Disciplinas de las Ciencias Biológicas
/
Consenso
/
Glucosa
/
Hematócrito
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
Ko
Revista:
Laboratory Medicine Online
Año:
2018
Tipo del documento:
Article